J J Criado-Alvarez

Summary

Affiliation: Hospital Virgen de la Salud
Country: Spain

Publications

  1. ncbi request reprint [Use of pyrazinamide as an indicator of tuberculosis epidemiology in Castilla-La Mancha]
    J J Criado-Alvarez
    Sección de Investigación Epidemiológica, Instituto de Ciencias de la Salud de Castilla La Mancha, Consejería de Sanidad Junta de Comunidades de Castilla La Mancha
    Rev Clin Esp 204:298-302. 2004
  2. ncbi request reprint [Estimate of type I bipolar disorder prevalence (1996-1998)]
    J J Criado-Alvarez
    Sección de Investigación Epidemiológica, Junta de Comunidades de Castilla La Mancha
    Rev Esp Salud Publica 74:131-8. 2000
  3. ncbi request reprint [Potential impact of measures to minimise costs of pharmaceutical provision in the province of Toledo]
    J J Criado-Alvarez
    Instituto de Ciencias de la Salud de Castilla La Mancha, Consejeria de Sanidad, 45600 Talavera de la Reina Toledo, Spain
    Aten Primaria 33:126-30. 2004
  4. ncbi request reprint [Mortality attributable to tobacco consumption in the years 1987 and 1997 in Castilla la Mancha, Spain]
    Juan José Criado-Alvarez
    Sección de Investigación Epidemiológica, Instituto de Ciencias de la Salud de Castilla La Mancha, Consejeria de Sanidad, Junta de Comunidades de Castilla La Mancha
    Rev Esp Salud Publica 76:27-36. 2002
  5. ncbi request reprint [Variability and tendencies in the consumption of methylphenidate in Spain. An estimation of the prevalence of attention deficit hyperactivity disorder]
    J J Criado Alvarez
    Instituto de Ciencias de la Salud de Castilla La Mancha, Talavera de la Reina, Toledo, Espana
    Rev Neurol 37:806-10. 2003
  6. ncbi request reprint [Factors associated with the degree of disability among patients of the Spanish Multiple Sclerosis Association of the Community of Madrid]
    J J Criado Alvarez
    , , Talavera de la Reina, Toledo
    Rev Neurol 25:1539-44. 1997
  7. ncbi request reprint [Variability and trends in dementia drug consumption in Castile-La Mancha (Spain). Estimated prevalence of Alzheimer's disease]
    J J Criado-Alvarez
    Unidad Docente de Medicina Familiar y Comunitaria, Gerencia de Atención Primaria de Talavera de la Reina, SESCAM, Toledo, Centro de Estudios Universitarios de Talavera de la Reina, Universidad de Castilla La Mancha, Toledo, Espana
    Neurologia 25:234-8. 2010
  8. ncbi request reprint [Use of antiparkinsonian agents in Castilla-La Mancha. Estimate of prevalence of Parkinson disease]
    J J Criado Alvarez
    Servicio de Asistencia Sanitaria, , Toledo,
    Rev Neurol 27:405-8. 1998
  9. ncbi request reprint [Estimate of the prevalence of hypothyroidism in Spain based on the use of thyroid hormones (1996-1999)]
    C Morant Ginestar
    , , Km 114, 45600-Talavera de la Reina, Toledo
    Rev Esp Salud Publica 75:337-44. 2001
  10. ncbi request reprint [Mortality due to alcohol consumption in Castilla-La Mancha [Spain], 1980-1998]
    J J Criado-Alvarez
    Gac Sanit 17:438-9. 2003

Collaborators

Detail Information

Publications10

  1. ncbi request reprint [Use of pyrazinamide as an indicator of tuberculosis epidemiology in Castilla-La Mancha]
    J J Criado-Alvarez
    Sección de Investigación Epidemiológica, Instituto de Ciencias de la Salud de Castilla La Mancha, Consejería de Sanidad Junta de Comunidades de Castilla La Mancha
    Rev Clin Esp 204:298-302. 2004
    ....
  2. ncbi request reprint [Estimate of type I bipolar disorder prevalence (1996-1998)]
    J J Criado-Alvarez
    Sección de Investigación Epidemiológica, Junta de Comunidades de Castilla La Mancha
    Rev Esp Salud Publica 74:131-8. 2000
    ..The prevalence of Type I Bipolar Disorders is calculated by the degree to which lithium carbonate is used...
  3. ncbi request reprint [Potential impact of measures to minimise costs of pharmaceutical provision in the province of Toledo]
    J J Criado-Alvarez
    Instituto de Ciencias de la Salud de Castilla La Mancha, Consejeria de Sanidad, 45600 Talavera de la Reina Toledo, Spain
    Aten Primaria 33:126-30. 2004
    ..To analyze the potential saving in the pharmaceutical cost that would suppose the use of equivalent pharmaceutical specialties and smaller price, in the main groups of pharmaceutical cost in 1998...
  4. ncbi request reprint [Mortality attributable to tobacco consumption in the years 1987 and 1997 in Castilla la Mancha, Spain]
    Juan José Criado-Alvarez
    Sección de Investigación Epidemiológica, Instituto de Ciencias de la Salud de Castilla La Mancha, Consejeria de Sanidad, Junta de Comunidades de Castilla La Mancha
    Rev Esp Salud Publica 76:27-36. 2002
    ..The aim of this work was to describe the mortality attributable to tobacco consumption in Castilla la Mancha between 1987 and 1997...
  5. ncbi request reprint [Variability and tendencies in the consumption of methylphenidate in Spain. An estimation of the prevalence of attention deficit hyperactivity disorder]
    J J Criado Alvarez
    Instituto de Ciencias de la Salud de Castilla La Mancha, Talavera de la Reina, Toledo, Espana
    Rev Neurol 37:806-10. 2003
    ..Methylphenidate (MPH) is the only medication available on the Spanish market...
  6. ncbi request reprint [Factors associated with the degree of disability among patients of the Spanish Multiple Sclerosis Association of the Community of Madrid]
    J J Criado Alvarez
    , , Talavera de la Reina, Toledo
    Rev Neurol 25:1539-44. 1997
    ..29) and a current age of over 35 years old (OR = 2.86). CONCLUSIONS: The reduction in number and frequency of exacerbations or their prevention may reduce progression of the disorder and disability in daily life...
  7. ncbi request reprint [Variability and trends in dementia drug consumption in Castile-La Mancha (Spain). Estimated prevalence of Alzheimer's disease]
    J J Criado-Alvarez
    Unidad Docente de Medicina Familiar y Comunitaria, Gerencia de Atención Primaria de Talavera de la Reina, SESCAM, Toledo, Centro de Estudios Universitarios de Talavera de la Reina, Universidad de Castilla La Mancha, Toledo, Espana
    Neurologia 25:234-8. 2010
    ..We believe that the prevalence in Spain is between 4-11% for the population over 65 years-old. Drugs are currently available to treat this disease in its different phases...
  8. ncbi request reprint [Use of antiparkinsonian agents in Castilla-La Mancha. Estimate of prevalence of Parkinson disease]
    J J Criado Alvarez
    Servicio de Asistencia Sanitaria, , Toledo,
    Rev Neurol 27:405-8. 1998
    ..CONCLUSIONS: The numbers obtained place to CLM in a middle-high prevalence; although methodological differences do not allow definitive conclusions...
  9. ncbi request reprint [Estimate of the prevalence of hypothyroidism in Spain based on the use of thyroid hormones (1996-1999)]
    C Morant Ginestar
    , , Km 114, 45600-Talavera de la Reina, Toledo
    Rev Esp Salud Publica 75:337-44. 2001
    ..The reason for the increased consumption found could best be said to lie in this disease being diagnosed to a better degree more than its being due to any actual increase in prevalence per se...
  10. ncbi request reprint [Mortality due to alcohol consumption in Castilla-La Mancha [Spain], 1980-1998]
    J J Criado-Alvarez
    Gac Sanit 17:438-9. 2003